Close X
Attorney Spotlight

How does Jordana Nelson's prior experience as a general counsel inform her work with firm clients? Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

The M&A Advisor Winner 2017The M&A Advisor announced the winners of the 16th Annual M&A Advisor Awards on Monday, November 13 at the 2017 M&A Advisor Awards. Bass, Berry & Sims was named a winner in the two categories related to the following deals:

M&A Deal of the Year (from $1B-$5B) – Acquisition of CLARCOR Inc. by Parker Hannifin Corporation

Corporate/Strategic Deal of the Year (over $1B) – Acquisition of BNC Bancorp by Pinnacle Financial Partners

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Regulation A+

It seems that lately there has been a noticeable uptick in Regulation A+ activity, including several recent Reg A+ securities offerings where the stock now successfully trades on national exchanges. In light of this activity, we have published a set of FAQs about Regulation A+ securities offerings to help companies better understand this "mini-IPO" offering process, as well as pros and cons compared to a traditional underwritten IPO.

Read now

Defense of Wyeth Pharmaceuticals Inc. in Fen-Phen Class Actions

Client Type: Public Company

We represented Wyeth Pharmaceuticals Inc. in the defense of approximately 2,500 cases filed in Tennessee related to the anti-obesity drug fen-phen. Our representation included:

  • Review of the pertinent studies and medical literature for the defense of these cases
  • Retaining experts who were effective for trials set nationwide
  • Review of echocardiograms with experts for defense of cases
  • Collection and summarizing of medical records for cases
  • Jessie Zeigler served on the national expert team and quality assurance/quality control  team for cases that were set for trial nationally
  • Taking plaintiffs' depositions and taking experts' depositions across the country
Most of the local cases were ultimately settled by Wyeth after a successful defense strategy of calling into question the validity of numerous cases through favorable testimony at depositions of both the plaintiffs and their experts.

Wyeth Pharmaceuticals was a publicly traded pharmaceutical company until it was purchased by Pfizer in 2009.

You Also May Be Interested In:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.